Hefei Lifeon Pharmaceutical Co., Ltd. at its annual general meeting of 2022 held on 08 May 2023, approved 2022 profit distribution plan as cash dividend (tax included) CNY 5.00000000 per ten shares.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.99 CNY | -0.99% | +3.04% | -14.78% |
May. 21 | Lifeon Pharmaceutical's Unit Gets Marketing Authorization for Loxoprofen Sodium Oral Solution | MT |
May. 15 | Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.78% | 528M | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- 003020 Stock
- News Hefei Lifeon Pharmaceutical Co., Ltd.
- Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023